ISO 11239:2023

Overview

ISO 11239:2023 - Health informatics - Identification of medicinal products - defines the data elements, structures and relationships needed to uniquely identify and exchange regulated information about pharmaceutical dose forms, units of presentation, routes of administration and packaging. Part of the IDMP family, this ISO standard specifies controlled vocabularies, a translation mechanism, and versioning and mapping rules to support consistent international exchange of medicinal product descriptors.

Key topics and technical requirements

• High‑level concepts defined: pharmaceutical dose form, unit of presentation, route of administration and packaging (containers, closures, administration devices).
• Data elements and schema: standardized data structures and relationships required to exchange unambiguous identification information.
• Controlled vocabularies: finite sets of allowed values (codes, terms) to ensure consistent representation of dose forms, presentation units, routes and packaging.
• Terms & codes model: use of coded concept and code‑term pairs to manage multilingual and regional variants of the same concept.
• Translations mechanism: association of translations for a single concept across languages and geographies as an integral part of exchange.
• Versioning: mechanism to track evolution of concepts and maintain provenance for changes over time.
• Mapping guidance: rules to help regional authorities and stakeholders map existing regional terms to the standardized terms in a harmonized way.
• Normative references: alignment with ISO 639‑1 (language codes) and ISO 3166‑1 (country codes) for language and region identifiers.

Practical applications

• Enables reliable, machine‑readable exchange of regulated medicinal product descriptors between stakeholders.
• Supports regulatory activities including registration, life‑cycle management, pharmacovigilance, risk management and reporting.
• Facilitates interoperability in electronic submission systems, regulatory databases, EHR integrations and global product registries.
• Improves consistency for adverse event reporting where precise dose form or route may be unknown (use of basic dose form or administration method).

Who uses this standard

• National and regional medicines regulatory authorities
• Pharmaceutical companies (regulatory affairs, product data management)
• Health informatics implementers, EHR and clinical trial data integrators
• Terminology and controlled‑vocabulary providers
• Pharmacovigilance and safety surveillance teams

Related standards

• ISO 11615, ISO 11616, ISO 11238 and ISO 11240 - other IDMP standards covering broader aspects of medicinal product identification and regulated data exchange.

Keywords: ISO 11239:2023, IDMP, health informatics, identification of medicinal products, pharmaceutical dose form, units of presentation, routes of administration, packaging, controlled vocabularies, translations, versioning, regulatory exchange.